3/8
09:31 am
virx
Thinking about buying stock in Quantum-Si, Victoria's Secret, Viracta Therapeutics, CERo Therapeutics, or Weyerhaeuser?
Medium
Report
Thinking about buying stock in Quantum-Si, Victoria's Secret, Viracta Therapeutics, CERo Therapeutics, or Weyerhaeuser?
3/7
04:05 pm
virx
Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Medium
Report
Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2/29
08:14 am
virx
Viracta Therapeutics Announces Completion of Second-Stage Enrollment into the Peripheral T-Cell Lymphoma Cohort of the NAVAL-1 Trial [Yahoo! Finance]
High
Report
Viracta Therapeutics Announces Completion of Second-Stage Enrollment into the Peripheral T-Cell Lymphoma Cohort of the NAVAL-1 Trial [Yahoo! Finance]
2/29
08:00 am
virx
Viracta Therapeutics Announces Completion of Second-Stage Enrollment into the Peripheral T-Cell Lymphoma Cohort of the NAVAL-1 Trial
High
Report
Viracta Therapeutics Announces Completion of Second-Stage Enrollment into the Peripheral T-Cell Lymphoma Cohort of the NAVAL-1 Trial
2/6
04:05 pm
virx
Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Medium
Report
Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
1/5
08:02 am
virx
Viracta Therapeutics, Inc. (NASDAQ: VIRX) had its price target lowered by analysts at HC Wainwright from $10.00 to $4.00. They now have a "buy" rating on the stock.
Low
Report
Viracta Therapeutics, Inc. (NASDAQ: VIRX) had its price target lowered by analysts at HC Wainwright from $10.00 to $4.00. They now have a "buy" rating on the stock.
1/4
08:44 am
virx
Ashvattha Therapeutics Announces the Appointment of Mehdi Paborji as Senior Vice President of Technical Operations [Yahoo! Finance]
Low
Report
Ashvattha Therapeutics Announces the Appointment of Mehdi Paborji as Senior Vice President of Technical Operations [Yahoo! Finance]
1/4
08:09 am
virx
Viracta Therapeutics Provides Clinical Update and Outlook for 2024 [Yahoo! Finance]
Low
Report
Viracta Therapeutics Provides Clinical Update and Outlook for 2024 [Yahoo! Finance]
1/4
08:00 am
virx
Viracta Therapeutics Provides Clinical Update and Outlook for 2024
Medium
Report
Viracta Therapeutics Provides Clinical Update and Outlook for 2024